Filing Summary
Business Context and Reporting Period
This Form 8-K was filed by Foresight Acquisition Corp. on December 1, 2021, reporting events from the reconvened special stockholder meeting held November 24, 2021. Foresight was pursuing transactions involving P3 Health Partners Inc. under the merger and transaction agreements described in its proxy statement.
Key Metrics and Financial Information
The filing is limited to voting matters and does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating and financial metrics.
- Shares of Class A common stock outstanding as of the October 8, 2021 record date: 40,363,750.
- Shares represented at the reconvened meeting: 28,496,046, equal to 70.6% of voting power and sufficient to constitute a quorum.
- Adjournment proposal votes: 26,150,988 for, 2,290,958 against, and 54,100 abstentions.
Material Changes, Outlook, and Risks
Stockholders approved the proposal to adjourn the special meeting to allow additional solicitation and voting if needed for the approval of other transaction-related proposals. The meeting was adjourned to 7:00 a.m. Central Time on December 3, 2021.
The filing does not announce approval or closing of the proposed business combination. The need for additional solicitation and the continued meeting process indicate that transaction approvals remained unresolved as of the filing. No management financial guidance, operating outlook, contingencies, or unusual financial items are provided.
Investor Verification Items
- Verify the status and final voting results of the remaining transaction-related proposals at the December 3, 2021 reconvened meeting.
- Review the October 28, 2021 proxy statement for the terms, conditions, financing, dilution, and closing requirements of the proposed P3 Health Partners transaction.
- Confirm whether the business combination ultimately closed and identify any subsequent amendments, redemptions, or financing changes.